P66 Adalimumab originator versus biosimilar in children and young people with JIA
Author(s) -
Lianne KearsleyFleet,
Sarthak Jain,
Eileen Baildam,
Michael W. Beresford,
Sharon Douglas,
Helen Foster,
T. R. E. Southwood,
Kimme L Hyrich
Publication year - 2022
Publication title -
rheumatology advances in practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.539
H-Index - 4
ISSN - 2514-1775
DOI - 10.1093/rap/rkac067.066
Subject(s) - medicine , adalimumab , biosimilar , demographics , etanercept , physical therapy , disease , pediatrics , rheumatoid arthritis , demography , sociology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom